In recent trading, shares of Campbell's Company (Symbol: CPB) have crossed above the average analyst 12-month target price of $19.35, changing hands for $19.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of APA Corp (Symbol: APA) have crossed above the average analyst 12-month target price of $45.22, changing hands for $45.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, o
In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $110.45, changing hands for $119.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of LXP Industrial Trust (Symbol: LXP) have crossed above the average analyst 12-month target price of $61.00, changing hands for $61.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
(RTTNews) - The following biotech stocks reached a 52-week high on October 8, 2026, driven by catalysts such as reports of an upcoming acquisition or upcoming financial reports.
(RTTNews) - Indian shares rose sharply on Friday, rebounding after two consecutive sessions of losses as oil prices fell and global bond yields steadied, helping ease concerns around inflation and interest rates.
(RTTNews) - bioAffinity Technologies Inc. (BIAF), a biotechnology company developing noninvasive tests for lung disease, has agreed to raise approximately $4 million through a registered direct offering, alongside a concurrent private placement of warrants.
(RTTNews) - A day after falling to a two-month low, Germany's equity benchmark DAX rebounded strongly on Friday as stocks gained in strength, buoyed by comments from U.S. President Donald Trump that the U.S. will not attack Iran before the midterm elections next month. He also sa
(RTTNews) - XORTX Therapeutics Inc. (XRTX), a clinical-stage pharmaceutical company, outlined plans to submit a Clinical Trial Application (CTA) to Health Canada for XORLO (XRx-026), its investigational oxypurinol-based drug candidate for gout.
Pump-and-dump stock scams are nothing new. These scams have been a mainstay of financial fraudsters for decades. And while technology has changed the way they operate, their basic framework and the end goal behind these unlawful practices remain the same.
(RTTNews) - Gold prices were sharply higher on Friday as oil prices fell and bond yields steadied, helping ease concerns around inflation and interest rates.
(RTTNews) - Basel Medical Group Ltd. (BMGL), a Singapore-based healthcare provider, has priced a registered direct offering of 6 million units at $1.33 per unit.
Reliable information is an essential part of making informed investment decisions. FINRA and other industry regulators offer free tools and resources to help investors research investment professionals, firms and products with confidence.